Suppr超能文献

艾滋病病毒血清学不一致夫妇的抗逆转录病毒干预措施的健康经济学建模。

Health economics modeling of antiretroviral interventions amongst HIV serodiscordant couples.

机构信息

Department of Preventive Medicine, Shantou University Medical College, No. 22 Xinling Road, Shantou, 515041, China.

Department of Preventive Medicine, School of Public Health and Management, Wenzhou Medical University, University Town, Wenzhou, 325035, China.

出版信息

Sci Rep. 2021 Jul 7;11(1):13967. doi: 10.1038/s41598-021-93443-x.

Abstract

Antiretroviral treatment (ART) and pre-exposure prophylaxis (PrEP) for HIV-serodiscordant couples, effectively reduce mortality, transmission events and influence quality of life at the expense of increased costs. We aimed to evaluate health economics of antiretroviral-based strategies for HIV-serodiscordant couples in the China context. A deterministic model of HIV evolution and transmission within a cohort of serodiscordant couples was parameterized using the real-world database of Zhoukou city and published literature. We evaluated the mid-ART (a historical strategy, initiating ART with CD4 < 500 cells/mm), early-ART (the current strategy, offering ART regardless of CD4 cell counts) and a hypothetical strategy (early-ART combined short-term daily PrEP) versus the late-ART (the baseline strategy, initiating ART with CD4 < 350 cells/mm) offered by 2008 national guidelines. We estimated the incremental cost-effectiveness ratios (ICER) and incremental cost-utility ratios (ICUR) from a societal perspective, derived by clinical benefits and HIV-caused life quality respectively, and portrayed their changes over a 0-30 year's timeframe. The model projections indicated that the antiretroviral-based interventions were more likely to obtain clinical benefits but difficult to improve quality of life, and cumulative ICER and ICUR were generally decreasing without achieving cost-saving. Scale-up access to ART for the HIV-positive among serodiscordant couples was easily fallen within the range of paying for incremental life-years and quality adjusted life years by the societal willingness. The hypothetical strategy had the potential to prevent most seroconversion events within marriages but required enormous upfront costs, thus it took a long time to reach established thresholds. The current strategy of early-ART is the most cost-effective. Clarifying the obstacles of high cost of PrEP and improving life quality for HIV-serodiscordant couples have emerged as an urgent requisition.

摘要

抗逆转录病毒治疗 (ART) 和 HIV 血清学不一致夫妇的暴露前预防 (PrEP),有效降低死亡率、传播事件和影响生活质量,但代价是增加成本。我们旨在评估中国 HIV 血清学不一致夫妇基于抗逆转录病毒的策略的健康经济学。使用周口市的真实世界数据库和已发表的文献,对 HIV 血清学不一致夫妇队列中的 HIV 进化和传播的确定性模型进行了参数化。我们评估了中程 ART(历史策略,CD4<500 个细胞/mm 时开始 ART)、早期 ART(当前策略,无论 CD4 细胞计数如何都提供 ART)和假设策略(早期 ART 联合短期每日 PrEP)与 2008 年国家指南提供的晚期 ART(基线策略,CD4<350 个细胞/mm 时开始 ART)进行了比较。我们从社会角度估计了增量成本效益比(ICER)和增量成本效用比(ICUR),分别来自临床效益和 HIV 导致的生活质量,描绘了它们在 0-30 年时间框架内的变化。模型预测表明,基于抗逆转录病毒的干预措施更有可能获得临床效益,但难以改善生活质量,累积 ICER 和 ICUR 通常在没有达到成本节约的情况下下降。扩大对血清学不一致夫妇中 HIV 阳性者的 ART 可及性,很容易在社会愿意为额外的生命年和质量调整生命年支付的范围内。假设策略有可能在婚姻内预防大多数血清转换事件,但需要巨大的前期成本,因此需要很长时间才能达到既定的门槛。早期 ART 的当前策略是最具成本效益的。解决 PrEP 高成本的障碍和提高 HIV 血清学不一致夫妇的生活质量已成为当务之急。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/692a/8263699/01e34c06971c/41598_2021_93443_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验